Supplemental Table 1 and 2 from ERK Mutations Confer Resistance to Mitogen-Activated Protein Kinase Pathway Inhibitors

Eva M. Goetz,Mahmoud Ghandi, Daniel J. Treacy,Nikhil Wagle,Levi A. Garraway

crossref（2023）

引用 0|浏览22

暂无评分

摘要

Supplemental Table 1 and 2. Amino acid substitutions for each significantly mutated ERK1/2 nucleotide for the ERK inhibitor screen (Table 1) or the RAF/MEK inhibitor screen (Table 2) and the accompanying resistance phenotype.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要